Historical Valuation
Prokidney Corp (PROK) is now in the Fair zone, suggesting that its current forward PS ratio of -8011.33 is considered Fairly compared with the five-year average of -5.39. The fair price of Prokidney Corp (PROK) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price：2.34
Fair
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Prokidney Corp (PROK) has a current Price-to-Book (P/B) ratio of -0.30. Compared to its 3-year average P/B ratio of -0.28 , the current P/B ratio is approximately 7.93% higher. Relative to its 5-year average P/B ratio of 41.26, the current P/B ratio is about -100.73% higher. Prokidney Corp (PROK) has a Forward Free Cash Flow (FCF) yield of approximately -46.48%. Compared to its 3-year average FCF yield of -65.05%, the current FCF yield is approximately -28.54% lower. Relative to its 5-year average FCF yield of -48.09% , the current FCF yield is about -3.33% lower.
P/B
Median3y
-0.28
Median5y
41.26
FCF Yield
Median3y
-65.05
Median5y
-48.09
Competitors Valuation Multiple
AI Analysis for PROK
The average P/S ratio for PROK competitors is -1329.92, providing a benchmark for relative valuation. Prokidney Corp Corp (PROK.O) exhibits a P/S ratio of -8011.33, which is 502.39% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
Performance Decomposition
AI Analysis for PROK
1Y
3Y
5Y
Market capitalization of PROK increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of PROK in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is PROK currently overvalued or undervalued?
Prokidney Corp (PROK) is now in the Fair zone, suggesting that its current forward PS ratio of -8011.33 is considered Fairly compared with the five-year average of -5.39. The fair price of Prokidney Corp (PROK) is between to according to relative valuation methord.
What is Prokidney Corp (PROK) fair value?
PROK's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Prokidney Corp (PROK) is between to according to relative valuation methord.
How does PROK's valuation metrics compare to the industry average?
The average P/S ratio for PROK's competitors is -1329.92, providing a benchmark for relative valuation. Prokidney Corp Corp (PROK) exhibits a P/S ratio of -8011.33, which is 502.39% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
What is the current P/B ratio for Prokidney Corp (PROK) as of Jan 10 2026?
As of Jan 10 2026, Prokidney Corp (PROK) has a P/B ratio of -0.30. This indicates that the market values PROK at -0.30 times its book value.
What is the current FCF Yield for Prokidney Corp (PROK) as of Jan 10 2026?
As of Jan 10 2026, Prokidney Corp (PROK) has a FCF Yield of -46.48%. This means that for every dollar of Prokidney Corp’s market capitalization, the company generates -46.48 cents in free cash flow.
What is the current Forward P/E ratio for Prokidney Corp (PROK) as of Jan 10 2026?
As of Jan 10 2026, Prokidney Corp (PROK) has a Forward P/E ratio of -3.48. This means the market is willing to pay $-3.48 for every dollar of Prokidney Corp’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Prokidney Corp (PROK) as of Jan 10 2026?
As of Jan 10 2026, Prokidney Corp (PROK) has a Forward P/S ratio of -8011.33. This means the market is valuing PROK at $-8011.33 for every dollar of expected revenue over the next 12 months.